Nectin Therapeutics Raises $25M for Immuno-Oncology Therapies
- Nectin Therapeutics Ltd., (Nectin) a biotechnology company has extended its Series A financing to over $25M for immuno-oncology therapies
Source: hitconsultant.net
Pini Tsukerman News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pini Tsukerman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pini Tsukerman Today - Breaking & Trending Today
Israeli biotech company begins trial for cancer immuno-oncology solution
The company’s product, NTX1088, blocks the harmful overexpression of PVR proteins, which occurs in tumors caused by lung, breast, throat and other cancers.
Source: jpost.com
Israeli co Nectin Therapeutics raises $25m
Jerusalem-based Nectin is developing novel targeted immunotherapies to address resistance to approved immuno-oncology treatments.
Source: globes.co.il